Benitec Biopharma annual operating margin
2019
2020
2021
2022
2023
Benitec Biopharma Operating Margin Growth & History (BNTC)
Benitec Biopharma's operating margin was −25,441.33% for fiscal 2023.
View full Benitec Biopharma company overviewBenitec Biopharma annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-06-30 | −25,441.33% | −983.80 pp |
| 2022 | 2022-06-30 | −24,457.53% | −1413.47 pp |
| 2021 | 2021-06-30 | −23,044.07% | −14506.95 pp |
| 2020 | 2020-06-30 | −8,537.11% | −8559.48 pp |
| 2019 | 2019-06-30 | 22.36% | — |
Benitec Biopharma quarterly operating margin
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q2.22
Q3.22
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2023 | 2023-06-30 | −65,000.00% | −45660.00 pp |
| Q3 2023 | 2023-03-31 | −8,038.89% | +184661.11 pp |
| Q2 2023 | 2022-12-31 | −40,071.43% | +339228.57 pp |
| Q3 2022 | 2022-03-31 | −7,208.33% | +318691.67 pp |
| Q2 2022 | 2021-12-31 | −19,340.00% | −14449.09 pp |
| Q4 2021 | 2021-06-30 | −192,700.00% | −185160.71 pp |
| Q3 2021 | 2021-03-31 | −379,300.00% | −376558.44 pp |
| Q2 2021 | 2020-12-31 | −325,900.00% | −322366.67 pp |
| Q1 2021 | 2020-09-30 | −4,890.91% | — |
| Q3 2020 | 2020-03-31 | −7,539.29% | — |
| Q2 2020 | 2019-12-31 | −2,741.56% | — |
| Q1 2020 | 2019-09-30 | −3,533.33% | — |
Benitec Biopharma operating margin trends
Across the available reported history, Benitec Biopharma's operating margin decreased from −24,457.53% to −25,441.33%, a change of −983.80 percentage points. The latest reported quarter, Q4 2023, shows −65,000.00%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Benitec Biopharma filings at SEC.gov ↗